{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:54:44Z","timestamp":1792068884296,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["PAPIIT-AV200225"],"award-info":[{"award-number":["PAPIIT-AV200225"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"Direcci\u00f3n General de Asuntos del Personal Acad\u00e9mico, Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","award":["PAPIIT-IN205326"],"award-info":[{"award-number":["PAPIIT-IN205326"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"UNAM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.bmc.2026.118817","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:15:14Z","timestamp":1791040514000},"page":"118817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Selective PTP1B inhibition by A-1331852: Uncompetitive kinetics and computational evidence for C-terminal engagement"],"prefix":"10.1016","volume":"143","author":[{"given":"Nathaly","family":"Vasquez-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Sosa-Peinado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Cort\u00e9s-Ben\u00edtez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mart\u00edn","family":"Gonz\u00e1lez-Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"33","key":"10.1016\/j.bmc.2026.118817_bb0005","doi-asserted-by":"crossref","first-page":"19810","DOI":"10.1074\/jbc.271.33.19810","article-title":"Protein-tyrosine phosphatase 1B is a negative regulator of insulin- and insulin-like growth factor-I-stimulated signaling","volume":"271","author":"Kenner","year":"1996","journal-title":"J Biol Chem"},{"issue":"51","key":"10.1016\/j.bmc.2026.118817_bb0010","doi-asserted-by":"crossref","first-page":"47771","DOI":"10.1074\/jbc.C100583200","article-title":"TYK2 and JAK2 are substrates of protein-tyrosine phosphatase 1B","volume":"276","author":"Myers","year":"2001","journal-title":"J Biol Chem"},{"issue":"6","key":"10.1016\/j.bmc.2026.118817_bb0015","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1158\/0008-5472.CAN-06-4610","article-title":"Protein-tyrosine phosphatase 1B is required for HER2\/Neu-induced breast cancer","volume":"67","author":"Bentires-Alj","year":"2007","journal-title":"Cancer Res"},{"issue":"10","key":"10.1016\/j.bmc.2026.118817_bb0020","doi-asserted-by":"crossref","first-page":"4098","DOI":"10.1182\/blood-2008-03-148726","article-title":"PTP1B is a negative regulator of interleukin 4-induced STAT6 signaling","volume":"112","author":"Lu","year":"2008","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.bmc.2026.118817_bb0025","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1080\/15384101.2014.998047","article-title":"Frequent amplification of PTP1B is associated with poor survival of gastric cancer patients","volume":"14","author":"Wang","year":"2015","journal-title":"Cell Cycle"},{"issue":"16","key":"10.1016\/j.bmc.2026.118817_bb0030","doi-asserted-by":"crossref","first-page":"21922","DOI":"10.18632\/oncotarget.7829","article-title":"Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome","volume":"7","author":"Hoekstra","year":"2016","journal-title":"Oncotarget"},{"issue":"10","key":"10.1016\/j.bmc.2026.118817_bb0035","doi-asserted-by":"crossref","first-page":"13479","DOI":"10.1007\/s13277-016-5245-1","article-title":"PTP1B promotes aggressiveness of breast cancer cells by regulating PTEN but not EMT","volume":"37","author":"Liu","year":"2016","journal-title":"Tumour Biol"},{"issue":"2","key":"10.1016\/j.bmc.2026.118817_bb0040","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1021\/jacs.5c18904","article-title":"Organoplatinum(II) type II immunogenic cell death inducers target protein tyrosine phosphatase 1B to drive immunogenicity","volume":"148","author":"Zou","year":"2026","journal-title":"J Am Chem Soc"},{"issue":"16","key":"10.1016\/j.bmc.2026.118817_bb0045","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.1021\/jm034088d","article-title":"Selective protein tyrosine phosphatase 1B inhibitors: targeting the second phosphotyrosine binding site with non-carboxylic acid-containing ligands","volume":"46","author":"Liu","year":"2003","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2026.118817_bb0050","doi-asserted-by":"crossref","first-page":"12019","DOI":"10.2147\/DDDT.S576701","article-title":"Drug repurposing as an effective drug discovery strategy: a critical review","volume":"19","author":"Al Khzem","year":"2025","journal-title":"Drug Des Devel Ther"},{"issue":"10","key":"10.1016\/j.bmc.2026.118817_bb0055","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1021\/acsmedchemlett.9b00568","article-title":"Discovery of A-1331852, a first-in-class, potent, and orally-bioavailable BCL-X(L) inhibitor","volume":"11","author":"Wang","year":"2020","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2026.118817_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115738","article-title":"BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells","volume":"215","author":"Chiou","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"10.1016\/j.bmc.2026.118817_bb0065","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41418-024-01417-z","article-title":"HRK downregulation and augmented BCL-xL binding to BAK confer apoptotic protection to therapy-induced senescent melanoma cells","volume":"32","author":"Alcon","year":"2025","journal-title":"Cell Death Differ"},{"issue":"3","key":"10.1016\/j.bmc.2026.118817_bb0070","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1158\/2159-8290.CD-21-0694","article-title":"PTP1B is an intracellular checkpoint that limits T-cell and CAR T-cell antitumor immunity","volume":"12","author":"Wiede","year":"2022","journal-title":"Cancer Discov"},{"issue":"2","key":"10.1016\/j.bmc.2026.118817_bb0075","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bmcl.2018.11.047","article-title":"BH3 mimetics derived from Bim-BH3 domain core region show PTP1B inhibitory activity","volume":"29","author":"Lu","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"10.1016\/j.bmc.2026.118817_bb0080","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1021\/acsmedchemlett.1c00174","article-title":"Discovery of novel PTP1B inhibitors derived from the BH3 domain of proapoptotic Bcl-2 proteins with antidiabetic potency","volume":"12","author":"Zhang","year":"2021","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"10.1016\/j.bmc.2026.118817_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/pro.70016","article-title":"Allosteric regulation of the tyrosine phosphatase PTP1B by a protein-protein interaction","volume":"34","author":"Chartier","year":"2025","journal-title":"Protein Sci"},{"issue":"11","key":"10.1016\/j.bmc.2026.118817_bb0090","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202101084","article-title":"Quantitative proteomics identifies PTP1B as modulator of B cell antigen receptor signaling","volume":"4","author":"Schwarz","year":"2021","journal-title":"Life Sci Alliance"},{"issue":"7","key":"10.1016\/j.bmc.2026.118817_bb0095","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/1521-4141(200207)32:7<1847::AID-IMMU1847>3.0.CO;2-7","article-title":"The anti-apoptotic molecules Bcl-xL and Bcl-w target protein phosphatase 1alpha to bad","volume":"32","author":"Ayll\u00f3n","year":"2002","journal-title":"Eur J Immunol"},{"issue":"5","key":"10.1016\/j.bmc.2026.118817_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0301866","article-title":"AlphaFold2 modeling and molecular dynamics simulations of an intrinsically disordered protein","volume":"19","author":"Guo","year":"2024","journal-title":"PLoS One"},{"issue":"15","key":"10.1016\/j.bmc.2026.118817_bb0105","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1002\/1873-3468.14901","article-title":"Protein tyrosine phosphatase 1B (PTP1B) function, structure, and inhibition strategies to develop antidiabetic drugs","volume":"598","author":"Coronell-Tovar","year":"2024","journal-title":"FEBS Lett"},{"issue":"6","key":"10.1016\/j.bmc.2026.118817_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/pro.5024","article-title":"Native dynamics and allosteric responses in PTP1B probed by high-resolution HDX-MS","volume":"33","author":"Woods","year":"2024","journal-title":"Protein Sci"},{"issue":"7","key":"10.1016\/j.bmc.2026.118817_bb0115","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nchembio.1528","article-title":"Targeting the disordered C terminus of PTP1B with an allosteric inhibitor","volume":"10","author":"Krishnan","year":"2014","journal-title":"Nat Chem Biol"},{"issue":"3","key":"10.1016\/j.bmc.2026.118817_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119264","article-title":"Automatic identification of mobile and rigid substructures in molecular dynamics simulations and fractional structural fluctuation analysis","volume":"10","author":"Mart\u00ednez","year":"2015","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.bmc.2026.118817_bb0125","doi-asserted-by":"crossref","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","article-title":"End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design","volume":"119","author":"Wang","year":"2019","journal-title":"Chem Rev"},{"issue":"5","key":"10.1016\/j.bmc.2026.118817_bb0130","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1021\/ci300526u","article-title":"Unraveling the allosteric inhibition mechanism of PTP1B by free energy calculation based on umbrella sampling","volume":"53","author":"Cui","year":"2013","journal-title":"J Chem Inf Model"},{"issue":"7","key":"10.1016\/j.bmc.2026.118817_bb0135","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1021\/acsmedchemlett.6c00242","article-title":"Uncompetitive allosteric inhibition of PTP1B by BP-1-102 reveals a potential dual-target strategy toward the PTP1B-STAT3 oncogenic axis: biochemical and computational evidence","volume":"17","author":"Gonz\u00e1lez-Andrade","year":"2026","journal-title":"ACS Med Chem Lett"},{"issue":"16","key":"10.1016\/j.bmc.2026.118817_bb0140","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.70446","article-title":"Kinetic compatibility as a predictor of PTP1B inhibitor combination outcomes: an integrated experimental and computational study","volume":"21","author":"Trapala","year":"2026","journal-title":"ChemMedChem"},{"issue":"42","key":"10.1016\/j.bmc.2026.118817_bb0145","doi-asserted-by":"crossref","first-page":"8427","DOI":"10.1021\/acs.jpcb.2c05423","article-title":"Allosteric inhibition of PTP1B by a nonpolar terpenoid","volume":"126","author":"Friedman","year":"2022","journal-title":"J Phys Chem B"},{"issue":"9","key":"10.1016\/j.bmc.2026.118817_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092234","article-title":"The structural biology of Bcl-x(L)","volume":"20","author":"Lee","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2026.118817_bb0155","doi-asserted-by":"crossref","first-page":"18301","DOI":"10.1074\/jbc.M109.095232","article-title":"Neuroprotectin D1 induces dephosphorylation of Bcl-xL in a PP2A-dependent manner during oxidative stress and promotes retinal pigment epithelial cell survival","volume":"285: (24)","author":"Antony","year":"2010","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.bmc.2026.118817_bb0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s12551-017-0346-7","article-title":"Unified understanding of folding and binding mechanisms of globular and intrinsically disordered proteins","volume":"10","author":"Arai","year":"2018","journal-title":"Biophys Rev"},{"issue":"36","key":"10.1016\/j.bmc.2026.118817_bb0165","doi-asserted-by":"crossref","first-page":"8704","DOI":"10.1021\/bi901171n","article-title":"Mapping the interaction of pro-apoptotic tBID with pro-survival BCL-XL","volume":"48","author":"Yao","year":"2009","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2026.118817_bb0170","doi-asserted-by":"crossref","first-page":"3760","DOI":"10.1016\/j.csbj.2023.07.017","article-title":"Structural basis of the specificity and interaction mechanism of Bmf binding to pro-survival Bcl-2 family proteins","volume":"21","author":"Wang","year":"2023","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"10.1016\/j.bmc.2026.118817_bb0175","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-65509-1","article-title":"Allosteric regulation of BH3-in-groove interactions by tail anchors of BCL-xL complexes limits BH3 mimetic antagonism","volume":"16","author":"Maillet","year":"2025","journal-title":"Nat Commun"},{"issue":"16","key":"10.1016\/j.bmc.2026.118817_bb0180","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"issue":"9","key":"10.1016\/j.bmc.2026.118817_bb0185","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J Comput Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118817_bb0190","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1021\/acs.jctc.9b00591","article-title":"ff19SB: amino-acid-specific protein backbone parameters trained against quantum mechanics energy surfaces in solution","volume":"16","author":"Tian","year":"2020","journal-title":"J Chem Theory Comput"},{"issue":"20","key":"10.1016\/j.bmc.2026.118817_bb0195","doi-asserted-by":"crossref","first-page":"6183","DOI":"10.1021\/acs.jcim.3c01153","article-title":"AmberTools","volume":"63","author":"Case","year":"2023","journal-title":"J Chem Inf Model"},{"issue":"10","key":"10.1016\/j.bmc.2026.118817_bb0200","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1002\/jcc.21787","article-title":"MDAnalysis: a toolkit for the analysis of molecular dynamics simulations","volume":"32","author":"Michaud-Agrawal","year":"2011","journal-title":"J Comput Chem"},{"issue":"1","key":"10.1016\/j.bmc.2026.118817_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0263-7855(96)00018-5","article-title":"VMD: visual molecular dynamics","volume":"14","author":"Humphrey","year":"1996","journal-title":"J Mol Graph"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089626002737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T12:34:37Z","timestamp":1792067677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089626002737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":41,"alternative-id":["S0968089626002737"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118817","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective PTP1B inhibition by A-1331852: Uncompetitive kinetics and computational evidence for C-terminal engagement","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2026.118817","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"118817"}}